Involvement of RFX proteins in transcriptional activation from a Ras-responsive enhancer element

Archives of Dermatological Research

Volumn 295, Issue 11, 2004, Pages 482-489

  Maijgren, Susann ^a,b   Sur, Inderpreet ^a   Nilsson, Mats ^a,c   Toftgård, Rune ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SBL Vaccin AB ^*  (Sweden)

^c Box 32054   (Sweden)

Author keywords

Keratinocytes; Ras; RFX; Transcription

Indexed keywords

BETA GALACTOSIDASE; BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; RFX 3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL GROWTH; CELL STRAIN HEPG2; CONTROLLED STUDY; ENHANCER REGION; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; HELA CELL; HUMAN; HUMAN CELL; KERATINOCYTE; NUCLEOTIDE SEQUENCE; ONCOGENE H RAS; PLASMID; PRIORITY JOURNAL; SKIN CARCINOGENESIS; TRANSCRIPTION INITIATION;

ANTIBODIES; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); GENES, RAS; HELA CELLS; HUMANS; KERATINOCYTES; MUTAGENESIS; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 2142814400     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-004-0456-5     Document Type: Article

References (33)

1. Adam PJ, Regan CP, Hautmann MB, Owens GK (2000) Positive- and negative-acting Krüppel-like transcription factors bind a transforming growth factor β control element required for expression of the smooth muscle cell differentiation marker SM22α in vivo. J Biol Chem 275:37798-37806
2. Andersson G, Peterlin BM (1990) NF-X2 that binds to the DRA X2-box is activator protein 1. Expression cloning of c-Jun. J Immunol 145:3456-3462
3. Andreu T, Beckers T, Thoenes E, Hilgard P, von Melchner H (1998) Gene trapping identifies inhibitors of oncogenic transformation. The tissue inhibitor of metalloproteinases-3 (TIMP3) and collagen type I alpha2 (COL1A2) are epidermal growth factor-regulated growth repressors. J Biol Chem 273:13848-13854
4. Barbacid M (1987) ras genes. Annu Rev Biochem 56:779-827
5. Benoist C, Mathis D (1990) Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu Rev Immunol 8:681-715
6. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ (1998) Increasing complexity of Ras signaling. Oncogene 17:1395-1413
7. Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410:37-40
8. Chen L, Smith L, Johnson MR, Wang K, Diasio RB, Smith JB (2000) Activation of protein kinase C induces nuclear translocation of RFX1 and down-regulates c-myc via an intron 1 X box in undifferentiated leukemia HL-60 cells. J Biol Chem 275:32227-32233
9. Chinenov Y, Kerppola TK (2001) Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20:2438-2452
10. Du W, Lebowitz PF, Prendergast GC (1999) Elevation of alpha2(I) collagen, a suppressor of Ras transformation, is required for stable phenotypic reversion by farnesyltransferase inhibitors. Cancer Res 59:2059-2063
11. Emery P, Strubin M, Hofmann K, Bucher P, Mach B, Reith W (1996) A consensus motif in the RFX DNA binding domain and binding domain mutants with altered specificity. Mol Cell Biol 16:4486-4494
12. Iwama A, Pan J, Zhang P, Reith W, Mach B, Tenen DG, Sun Z (1999) Dimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains. Mol Cell Biol 19:3940-3950
13. Katan Y, Agami R, Shaul Y (1997) The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities. Nucleic Acids Res 25:3621-3628
14. Kolch W (2000) Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 351 Pt 2:289-305
15. Labrie C, Lee BH, Mathews MB (1995) Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter. Nucleic Acids Res 23:3732-3741
16. Nilsson M, Toftgård R, Bohm S (1995) Activated Ha-Ras but not TPA induces transcription through binding sites for activating transcription factor 3/Jun and a novel nuclear factor. J Biol Chem 270:12210-12218
17. Nilsson M, Ford J, Bohm S, Toftgård R (1997) Characterization of a nuclear factor that binds juxtaposed with ATF3/Jun on a composite response element specifically mediating induced transcription in response to an epidermal growth factor/Ras/Raf signaling pathway. Cell Growth Differ 8:913-920
18. Nordeen SK (1988) Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6:454-458
19. Ostapchuk P, Scheirle G, Hearing P (1989) Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region. Mol Cell Biol 9:2787-2797
20. Perez-Sala D, Rebollo A (1999) Novel aspects of Ras proteins biology: regulation and implications. Cell Death Differ 6:722-728.
21. Reith W, Barras E, Satola S, Kobr M, Reinhart D, Sanchez CH, Mach B (1989) Cloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation. Proc Natl Acad Sci U S A 86:4200-4204
22. Reith W, Herrero-Sanchez C, Kobr M, Silacci P, Berte C, Barras E, Fey S, Mach B (1990) MHC class II regulatory factor RFX has a novel DNA-binding domain and a functionally independent dimerization domain. Genes Dev 4:1528-1540
23. Reith W, Ucla C, Barras E, Gaud A, Durand B, Herrero-Sanchez C, Kobr M, Mach B (1994) RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins. Mol Cell Biol 14:1230-1244
24. Sengupta PK, Ehrlich M, Smith BD (1999) A methylation-responsive MDBP/ RFX site is in the first exon of the collagen alpha2(I) promoter. J Biol Chem 274:36649-36655
25. Sengupta PK, Fargo J, Smith BD (2002) The RFX family interacts at the collagen (COL1A2) start site and represses transcription. J Biol Chem 277:24926-24937
26. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-136
27. Shields JM, Pruitt K, McFall A, Shaub A, Der CJ (2000) Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol 10:147-154
28. Siegrist CA, Durand B, Emery P, David E, Hearing P, Mach B, Reith W (1993) RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer. Mol Cell Biol 13:6375-6384
29. Spandidos DA, Wilkie NM (1984) Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature 310:469-475
30. Struhl K (1990) In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds) Current protocols in molecular biology. Wiley, New York
31. Whitmarsh AJ, Davis RJ (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589-607
32. Wu SY, McLeod M (1995) The sak1+ gene of Schizosaccharomyces pombe encodes an RFX family DNA-binding protein that positively regulates cyclic AMP-dependent protein kinase-mediated exit from the mitotic cell cycle. Mol Cell Biol 15:1479-1488
33. Zhang XY, Jabrane-Ferrat N, Asiedu CK, Samac S, Peterlin BM, Ehrlich M (1993) The major histocompatibility complex class II promoter-binding protein RFX (NF-X) is a methylated DNA-binding protein. Mol Cell Biol 13:6810-6818